FG yet to show interest in proposed COVID-19 vaccine

Notice: Undefined index: banner_ad_width in /home/ayekooto/public_html/wp-content/plugins/quick-adsense-reloaded/includes/render-ad-functions.php on line 359

Notice: Undefined index: image_width in /home/ayekooto/public_html/wp-content/plugins/quick-adsense-reloaded/includes/render-ad-functions.php on line 359

Notice: Undefined index: banner_ad_height in /home/ayekooto/public_html/wp-content/plugins/quick-adsense-reloaded/includes/render-ad-functions.php on line 360

Notice: Undefined index: image_height in /home/ayekooto/public_html/wp-content/plugins/quick-adsense-reloaded/includes/render-ad-functions.php on line 360

 

Prof. Maurice Iwu, Chief Executive Officer (CEO) of Bioresources Development Group (BDG) and former INEC boss declared that the Federal Government is yet to show interest in treatment presented by his team of researchers for COVID-19.

Iwu announced this via a Zoom Conference session organised by Elombah Communications in collaboration with Njenje Media Ltd, tagged “Covid-19 and the proposed Vaccination Bill: Implications for Nigeria”.

Prof. Iwu who manages a team of researchers had presented a plant-based patented treatment for COVID-19 to the Minister of Science and Technology, Dr Ogbonnaya Onu.

He mentioned at the Zoom Conference however, that government is yet to show interest in the drug, thereafter requested the National Assembly to organise emergency Public hearing on this issue.

He further said the lawmakers through their management function should direct the concerned agency to fast track the process of validating the drug.

Iwu said that government needs to show interest in our drug, the money raised by private sectors can be deployed, it does not need to come to Prof. Iwu, it is information, the product is ours, but the information is already outside.

“There must be interest on the part of government that they want to test the drug, once the government shows interest, every other thing will fall in place.”

He said the lawmakers should consider a public hearing on the drug and ask why the validation for the drug is taking longer than necessary.

Reported by: Fatimah Oyesanmi